In 2021, Otsuka America Pharmaceutical, Inc. transferred its North American BreathTek business to Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials. This strategic acquisition is expected to enhance Meridian's standing in the market, particularly in gastrointestinal diagnostics. By integrating the BreathTek portfolio, Meridian can expand its offerings and leverage its existing expertise in the field. This move positions the company for increased growth and competitiveness within the gastrointestinal diagnostic solutions sector
